NRC Stock Summary and Trading Ideas (National Research | NASDAQ:NRC)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

National Research trades on the NASDAQ stock market under the symbol NRC.

As of January 20, 2026, NRC stock price declined to $21.89 with 111,813 million shares trading.

NRC has a beta of 0.57, meaning it tends to be less sensitive to market movements. NRC has a correlation of 0.03 to the broad based SPY ETF.

NRC has a market cap of $495.97 million. This is considered a Small Cap stock.

In the last 3 years, NRC traded as high as $47.60 and as low as $9.76.

The top ETF exchange traded funds that NRC belongs to (by Net Assets): VTI, IWM, VXF, DES, IWO.

NRC has outperformed the market in the last year with a price return of +28.7% while the SPY ETF gained +14.6%. NRC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +84.8% and +13.4%, respectively, while the SPY returned +1.2% and -2.1%, respectively.

NRC support price is $21.54 and resistance is $22.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NRC shares will trade within this expected range on the day.